BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Rubius Therapeutics

Rubius Therapeutics logo

Founded
2013
Geography
United States of America based
Funding
$245 M

Rubius is developing a new class of drugs, Red-Cell Therapeutics. Rubius is using advanced cellular therapies that harness the unique, inherent properties of red cells and marry them to the creative power of genetic engineering.

Technologies

Stem Cells Startups  

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet